Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$770M |
| 2 |
Crown Castle
CCI
|
+$678M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$557M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$437M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.22B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.04B |
| 3 |
Amazon
AMZN
|
+$661M |
| 4 |
SHPG
Shire pic
SHPG
|
+$478M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$457M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 17.77% |
| 3 | Healthcare | 14.23% |
| 4 | Communication Services | 13.04% |
| 5 | Financials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
501
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $6.51M | 0.01% |
369,899
-1,582
| -0.4% | -$28.2K |
|
|
TCP
502
DELISTED
TC Pipelines LP
TCP
| $6.46M | 0.01% |
117,427
-531
| -0.5% | -$30.4K |
|
|
TRHC
503
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $6.01M | 0.01% |
399,119
-6,075
| -1% | -$82K |
|
504
CALL
Tenet Healthcare
THC
$21.5B
| $5.8M | 0.01% |
+300,000
| New | +$5.23M |
|
505
Spyre Therapeutics
SYRE
$7.97B
| $5.36M | 0.01% |
55,867
-2,314
| -4% | -$320K |
|
506
Select Water Solutions
WTTR
$2.49B
| $5.26M | 0.01% |
+432,912
| New | +$6.18M |
|
|
EXAS
507
DELISTED
Exact Sciences
EXAS
| $5.1M | 0.01% |
144,245
+123,618
| +599% | +$3.82M |
|
|
TTSH
508
DELISTED
Tile Shop Holdings
TTSH
| $4.86M | 0.01% |
+235,366
| New | +$4.78M |
|
509
PUT
Insmed
INSM
$25.9B
| $4.63M | ﹤0.01% |
270,000
| – | – |
|
510
iRhythm Holdings
IRTC
$3.96B
| $4.07M | ﹤0.01% |
95,741
-830
| -0.9% | -$30.2K |
|
511
Hess Midstream
HESM
$5.08B
| $4.06M | ﹤0.01% |
+199,099
| New | +$4.75M |
|
512
Omega Healthcare
OHI
$13.9B
| $3.61M | ﹤0.01% |
109,246
+22,493
| +26% | +$744K |
|
513
ExxonMobil
XOM
$644B
| $3.58M | ﹤0.01% |
44,315
-701
| -2% | -$57.4K |
|
514
Johnson & Johnson
JNJ
$646B
| $3.54M | ﹤0.01% |
26,750
+5
| +0% | +$638 |
|
515
Berkshire Hathaway Class B
BRK.B
$1.08T
| $3.45M | ﹤0.01% |
20,385
+80
| +0.4% | +$13.3K |
|
516
Baxter International
BAX
$13.5B
| $3.44M | ﹤0.01% |
56,818
+25,905
| +84% | +$1.47M |
|
517
Tempest Therapeutics
TPST
$17.5M
| $3.42M | ﹤0.01% |
749
+2
| +0.3% | +$8.46K |
|
518
Waste Management
WM
$87.8B
| $3.38M | ﹤0.01% |
46,046
-96,462
| -68% | -$7.02M |
|
519
Emerson Electric
EMR
$86.6B
| $3.37M | ﹤0.01% |
56,586
+6,379
| +13% | +$378K |
|
|
XL
520
DELISTED
XL Group Ltd.
XL
| $3.37M | ﹤0.01% |
76,862
-3,044
| -4% | -$128K |
|
521
MacroGenics
MGNX
$263M
| $3.33M | ﹤0.01% |
189,970
+1,062
| +0.6% | +$20.3K |
|
522
APA Corp
APA
$14.9B
| $3.2M | ﹤0.01% |
66,809
+51,286
| +330% | +$2.53M |
|
523
UroGen Pharma
URGN
$2.13B
| $3.17M | ﹤0.01% |
+175,410
| New | +$3.05M |
|
524
State Street SPDR S&P Metals & Mining ETF
XME
$4.74B
| $3.05M | ﹤0.01% |
101,796
-6,526
| -6% | -$192K |
|
525
Elevance Health
ELV
$85.5B
| $2.82M | ﹤0.01% |
15,005
-2,567
| -15% | -$461K |
|
Similar funds
Jennison Associates's Q2 2017 Portfolio in Review
As of Q2 2017, Jennison Associates held 698 positions worth $94.3B, up 1.1% from $93.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates withdrew a net $3.11B in Q2 2017, closing 61 positions and reducing 332 holdings. Its most notable exit was NXP Semiconductors, an estimated $452M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Newell Brands worth $125M.
- Jennison Associates's largest Q2 2017 buy was Newell Brands: 2,328,211 shares worth $125M.
- Jennison Associates added most to McDonald's in Q2 2017, an estimated $770M increase.
- Jennison Associates's biggest Q2 2017 reduction was Nike, cutting an estimated $1.22B.
- Jennison Associates fully exited NXP Semiconductors in Q2 2017, selling an estimated $452M.
- Jennison Associates's ten largest holdings make up 27% of its $94.3B portfolio in Q2 2017.
- Jennison Associates opened 62 new positions and closed 61 in Q2 2017.
- Jennison Associates's portfolio value rose 1.1% quarter-over-quarter to $94.3B.
Based on Jennison Associates's 13F filing for Q2 2017, filed 4 Aug 2017.